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Supplemental Materials 
Material and Methods 
Crystallisation 
Crystallisation experiments were performed using the sitting-drop vapour diffusion method with the 
conditions provided by the JCSG+ Suite (Qiagen), the Crystal screen, Crystal screen 2, and the Natrix 
and Natrix 2 crystallization screens (all from Hampton Research, CA, USA). 
For the crystallisation experiments using the JCSG+ Suite, Crystal screen and Crystal screen 2 
conditions, pure lyophilized streptavidin (Mr = 16.62 kDa; Leinco Technologies Inc., St. Louis, Mo, 
USA) was reconstituted in Milli-Q water to a concentration of 23.5 mg/mL (NanoDrop1000 
spectrophotometer, Thermo Scientific, Wilmington, DE, USA), using a molar extinction coefficient at 
280 nm of 41.940. The aptamer StrepApt5 (gggaACGCaccGATCGCAggtTtccc, Sigma; Mr = 7.96 kDa) 
was dissolved in Milli-Q water to a concentration of 1 mM. Streptavidin and StrepApt5 were mixed in 
a ratio of 1 tetramer: 5 aptamers, yielding a final protein concentration of 10 mg/mL. Drops consisting 
of equal volumes of reservoir solution (1 µL) and Streptavidin-StrepApt5 complex were equilibrated 
over 400 µL reservoirs (JCSG+) or 450 µL reservoirs (Crystal screen and Crystal screen 2) at 20 °C. 
For crystallisation experiments using the Natrix and Natrix 2 crystallization screens, pure 
lyophilized streptavidin was reconstituted in Milli-Q water to a concentration of 25.5 mg/mL. 
StrepApt5 was dissolved in binding buffer (100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2 and 
20 mM Tris/HCl, pH 7.6) to a concentration of 1 mM. Streptavidin and StrepApt5 were mixed in a 
ratio of 1 tetramer:2.2 aptamers, yielding a final protein concentration of 10 mg/mL. The mixture was 
left at room temperature to allow complex formation. In addition, samples with only streptavidin or 
StrepApt5 were prepared by diluting them in the same way as the Streptavidin-StrepApt5 sample. 
Drops consisting of equal volumes of reservoir solution (2 µL) and either Streptavidin-StrepApt5 
complex, Streptavidin, or StrepApt5 were equilibrated over 450 µL reservoirs (JCSG+) at 20 °C. 
X-ray Data Collection and Analysis 
A crystal obtained using a reservoir solution consisting of 2.0 M ammonium sulphate and 5% v/v  
2-propanol (Crystal screen 2 condition 5) was used for data collection (Figure 3). For cryoprotection, 
the crystal was soaked in reservoir solution containing 25% (w/v) glycerol. The crystal was mounted in 
a cryoloop and flash frozen in a stream of nitrogen gas at 110 K. Diffraction data was collected in 
house at 110 K using a Microstar rotating anode (Cu) X-ray source (Bruker AXS GmbH) in 
combination with Helios optics (Incoatec GmbH) and a MAR345dtb detector (Marresearch GmbH). In 
total, 220 data images were collected with an oscillation angle of 1°. The data was processed using the 
iMosflm program [1] and programs from the CCP4 Suite [2]. For data collection statistics see Table S1.  
The structure of the crystallized protein was solved by molecular replacement using the program 
Phaser v.1.3 [3] with the native streptavidin structure (PDB code 3ry1; [4]) as the search model from 
which water and solvent molecules had been removed. After rigid-body refinement of the obtained 
solution, the R factor was 0.396. Further refinement was done with the program REFMAC5 [5], 
setting aside 5% of the reflections to monitor refinement progress with the Rfree factor, but was stopped 
when it was clear that no aptamer was bound to the protein. Table S1 lists the refinement statistics. 
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Table S1. X-ray data collection and refinement statistics. 
X-ray source In house Microstar rotating anode X-ray source  
(Bruker AXS GmbH) 
Wavelength (Å) 1.5418 Å 
Space group C2 
molecules/A.U 4 
Solvent content 36% (based on 64 kDa/tetramer) 
Unit-cell parameters  
a, b, c (Å) 83.9 47.6 104.7 
α, β, γ (º) 90 100 90 
Resolution (Å) 1.86 (1.96–1.86) * 
Rmerge 0.101 (0.638) 
Rp.i.m 0.056 (0.338) 
Total No. of observations 138644 (18185) 
Total No. of unique reflections 32195 (4221) 
Mean I/σ(I) 7.7 (1.8) 
Completeness (%) 93.8 (85.3) 




RMSD from target geometry  
Bond lengths (Å) 0.014 
Bond angles (°) 1.58 
Total number of atoms 3684 
Number of amino acids 475 (A: 16–136, B: 15–132, C: 15–133, D: 16–132) 
Number of water molecules 154 
Ramachandran analysis (%) [6]  
Core 88.8 
Allowed 10.3 
Generously Allowed 1.0 
Disallowed 0.0 
* Between brackets: Statistics for the highest resolution shell. 
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Table S2. Overview of crystals of streptavidin only and streptavidin-StrepApt5 complex in 
the same conditions. 
Condition Composition Streptavidin only Streptavidin-StrepApt5 complex 
Natrix 1 25 
0.08 M Magnesium 
acetate tetrahydrate, 
0.05 M Sodium 
cacodylate trihydrate 
pH 6.5, 30% w/v 
Polyethylene glycol 
4,000 
Natrix 1 27 
0.2 M Ammonium 
acetate, 0.01 M 
Magnesium acetate 
tetrahydrate, 0.05 M 
Sodium cacodylate 




Natrix 1 45 
0.025 M Magnesium 
sulfate hydrate,  
0.05 M TRIS 
hydrochloride pH 
8.5, 1.8 M 
Ammonium sulfate 
Natrix 1 48 
0.2 M Ammonium 
chloride, 0.01 M 
Calcium chloride 
dihydrate, 0.05 M 
TRIS hydrochloride 
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Figure S1. Sequence and secondary structure of StrepApt5. 
 
Figure S2. Structural analysis of streptavidin structure. (A) Electron density observed in 
the biotin-binding pocket of one of the subunits; density is present in all biotin-binding 
pockets; (B) The observed density is too small to have originated from an aptamer, but it 
neither corresponds to a full biotin molecule (shown in orange). We suspect it is a biotin 
analogue, used by the manufacturer to purify the protein. Unfortunately the resolution is 
not sufficient to identify the exact nature of this molecule; (C) Symmetry-related mates of 
the central streptavidin show that there is no physical space for a large DNA molecule. 
Biotins are shown as yellow spheres: 4 biotin molecules per streptavidin tetramer. 
  
(A) (B) (C) 
Figure S3. The structural model obtained from the collected data (unsuccessful attempt to 
obtain a streptavidin-aptamer structure) is shown in green. A biotin containing streptavidin 
structure (3MG5) [7] is shown in blue (biotins are hidden in this figure). 
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